Ignite Creation Date:
2025-12-24 @ 1:58 PM
Ignite Modification Date:
2025-12-28 @ 2:40 AM
Study NCT ID:
NCT01614795
Status:
COMPLETED
Last Update Posted:
2018-12-11
First Post:
2012-06-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06-18
Start Date Type:
ACTUAL
Primary Completion Date:
2014-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-06
First Submit QC Date:
None
Study First Post Date:
2012-06-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-19
Results First Submit QC Date:
None
Results First Post Date:
2015-03-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-16
Last Update Post Date:
2018-12-11
Last Update Post Date Type:
ACTUAL